Stonepine Capital Management, LLC Opti Nose, Inc. Transaction History
Stonepine Capital Management, LLC
- $158 Billion
- Q3 2024
A detailed history of Stonepine Capital Management, LLC transactions in Opti Nose, Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 5,688,590 shares of OPTN stock, worth $2.33 Million. This represents 2.41% of its overall portfolio holdings.
Number of Shares
5,688,590
Previous 2,350,010
142.07%
Holding current value
$2.33 Million
Previous $2.44 Billion
55.95%
% of portfolio
2.41%
Previous 2.23%
Shares
7 transactions
Others Institutions Holding OPTN
# of Institutions
62Shares Held
88.3MCall Options Held
0Put Options Held
0-
Mvm Partners, LLC Boston, MA14.6MShares$5.99 Million10.4% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT14.4MShares$5.89 Million0.57% of portfolio
-
Great Point Partners LLC Greenwich, CT12.9MShares$5.27 Million3.98% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY5.6MShares$2.3 Million0.45% of portfolio
-
Black Rock Inc. New York, NY5.27MShares$2.16 Million0.0% of portfolio
About OptiNose, Inc.
- Ticker OPTN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 83,277,504
- Market Cap $34.1M
- Description
- OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...